CTO Session

Dr. Darshan Doshi is an interventional cardiologist at the Massachusetts General Hospital who specializes in complex coronary interventions. He also helps directs the chronic total occlusions program, and leads imaging and physiology efforts in the cath lab. Dr. Doshi received his BA from Columbia University’s Columbia College and his MD from Columbia University’s College of Physicians and Surgeons. He completed his internal medicine residency, and his cardiovascular medicine and interventional cardiology fellowships at the Columbia University Medical Center. Dr. Doshi also underwent additional dedicated training at Columbia in complex and high-risk interventional procedures. He was then recruited to join the faculty in the Division of Cardiology at the Massachusetts General Hospital. Dr. Doshi also holds a MS in patient-oriented research from Columbia University’s Mailman School of Public Health with a research interest focused on clinical trials evaluating novel cardiovascular devices and therapeutics in interventional cardiology. He has authored several original manuscripts in translational and clinical cardiovascular medicine, and has published in the New England Journal of Medicine, Lancet, Journal of the American College of Cardiology, and Circulation, among many others.

Dr. Singh is an Associate Professor of Medicine, Medical Director, Cardiac Catheterization Laboratory at Barnes-Jewish Hospital and Director of Interventional Cardiology. He specializes in coronary and peripheral vascular interventional procedures and spends most of his time in the cardiac catheterization laboratory. His expertise is in complex coronary intervention and also the endovascular treatment of renovascular hypertension, and peripheral arterial occlusive diseases. In addition, he has been involved in research ranging from new coronary devices to intravascular ultrasound and pressure/flow assessment of coronary vessels. He is the Principal Investigator in several high profile multicenter trials evaluating the above. He is actively involved in resident/fellow education and rotate in the coronary care unit twice a year. He has two interventional fellows per year who work closely with him during their training, he also serves as their attending in ½ day in patient clinic. He has second and third year cardiology fellows involved in clinical research protocols in the cath lab and their work has produced three instrumental abstracts/papers which in the first 12 months were presented at major cardiovascular society meetings. Dr. Singh is also the Chairman of ARCH, one of the largest Midwest Interventional Symposium.

A director, cardiac catheterization laboratory at Henry Ford Hospital and Health System, Detroit, MI, USA. Features in 2 videos on Wondr Medical. Khaldoon Alaswad generally speaks on Impella, Cardiology, and Cardiovascular Surgery.

After completing his M.D. at Tulane Medical School, Bill Lombardi went on to the University of Utah, Salt Lake City for his internal medicine residency and fellowships in cardiology, heart failure/cardiac transplant, and interventional cardiology. Dr. Lombardi then returned home to Washington State and joined St. Joseph’s Hospital in Bellingham. During the 13 years that he was at St. Joseph’s, Dr. Lombardi helped to develop novel CTO techniques and technologies and was fundamental to the inception of the “hybrid algorithm” to facilitate reproducibly successful outcomes in chronic total occlusion and complex lesion PCI. During this time he was also active in physician training, CME courses and proctoring. Dr. Lombardi joined the University of Washington Medical Center in 2014 as associate clinical professor and director of the Complex Coronary Disease Therapies Program. He is certified in interventional cardiology and cardiovascular disease by the American Board of Internal Medicine. Dr. Lombardi's interests include sailing, fishing, and spending time with family.